Table 4 Multivariate logistic regression analysis of risk factors for adverse outcomes combined with different diagnostic criteria
Variables | Joint 2018 NICHD definition | Joint 2019 Jensen definition | ||
|---|---|---|---|---|
OR(95%CI) | P-value | OR(95%CI) | P-value | |
GA, w | 0.511 | 0.722 | ||
30 ≤ GA < 32 | 1.00 | — | 1.00 | — |
28 ≤ GA < 30 | 0.703(0.386–1.278) | 0.248 | 0.783(0.432–1.421) | 0.421 |
GA < 28 | 0.761(0.328–1.764) | 0.524 | 0.859(0.371–1.993) | 0.724 |
BW, g | 0.326 | 0.384 | ||
BW ≥ 1500 | 1.00 | — | 1.00 | — |
1000 ≤ BW < 1500 | 1.439(0.722–2.868) | 0.301 | 1.464(0.732–2.931) | 0.281 |
BW < 1000 | 2.117(0.793–5.651) | 0.134 | 1.998(0.743–5.373) | 0.170 |
EUGR at 36 weeks’ PMA | 1.069(0.598–1.913) | 0.821 | 1.013(0.565–1.817) | 0.965 |
Treatment with PS | 1.383(0.831–2.303) | 0.212 | 1.414(0.850–2.351) | 0.183 |
2018 BPD/2019 BPD | < 0.001 | < 0.001 | ||
No BPD | 1.00 | — | 1.00 | — |
Grade 1 BPD | 3.745(1.712–8.189) | 0.001 | 4.337(2.368–7.945) | < 0.001 |
Grade 2 BPD | 5.375(2.870−10.064) | < 0.001 | 14.569(6.732–31.527) | < 0.001 |
Grade 3 BPD | 23.961(11.359–50.541) | < 0.001 | 26.159(10.787–63.436) | < 0.001 |